Immunohistochemical profile of laryngeal cancers with different clinical course and efficiency of treatment.

The cancer of larynx is one of the most significant medical problems because of its high prevalence, high mortality and low survival rate. The retrospective analysis of specimens of 187 patients suffering from laryngeal squamous cell carcinoma of stage III-IV was performed. The purpose of our stud...

Full description

Bibliographic Details
Main Authors: Shponka I.S., Gritsenko P.A., Kovtunenko A.V.
Format: Article
Language:Russian
Published: Ministry of Health of Ukraine. Dnipropetrovsk Medical Academy 2007-01-01
Series:Морфологія
Subjects:
Online Access:http://www.morphology.dp.ua/_pub/MORPHO-2007-01-02/07sisnpt.pdf
_version_ 1811312728449482752
author Shponka I.S.
Gritsenko P.A.
Kovtunenko A.V.
author_facet Shponka I.S.
Gritsenko P.A.
Kovtunenko A.V.
author_sort Shponka I.S.
collection DOAJ
description The cancer of larynx is one of the most significant medical problems because of its high prevalence, high mortality and low survival rate. The retrospective analysis of specimens of 187 patients suffering from laryngeal squamous cell carcinoma of stage III-IV was performed. The purpose of our study was to substantiate the appropriateness of assessment of immunomorphological profile in estimation of biological behaviour of laryngeal cancer for prediction its clinical course and choice of optimal treatment. The routine histological examination with determination of type, histopathological grading and extention of tumors was performed. Molecular markers, such as CK19, CK34βЕ12, Ki-67, p53 and bcl-2 were analyzed by immunohistochemistry. Our findings were compared with the clinical course, presence of regional and distant metastasis, rate of relapses, one-year survival rate, and efficiency of treatment. The significant distinctions in marker expression among tumors with different clinical course and efficiency of treatment were determined which prove these markers prognostic significance. The cancers of the larynx with unfavorable clinical course had high proliferative activity, expression of р53, СК19 and low expression of СК34. The tumors that responded well to the treatment had high expression of р53 and low expression of bcl-2. The radiosensitive tumors also had high proliferative activity. The cancers which did not respond well to treatment had high expression of bcl-2 that allowed us to consider this marker to be independent factor of tumor resistance to treatment. These data give us the possibility to individualize treatment approaches to patients with laryngeal cancer.
first_indexed 2024-04-13T10:41:40Z
format Article
id doaj.art-ae915a4f7da34ea69aaea7ea35319119
institution Directory Open Access Journal
issn 1997-9665
language Russian
last_indexed 2024-04-13T10:41:40Z
publishDate 2007-01-01
publisher Ministry of Health of Ukraine. Dnipropetrovsk Medical Academy
record_format Article
series Морфологія
spelling doaj.art-ae915a4f7da34ea69aaea7ea353191192022-12-22T02:49:54ZrusMinistry of Health of Ukraine. Dnipropetrovsk Medical AcademyМорфологія1997-96652007-01-011295101Immunohistochemical profile of laryngeal cancers with different clinical course and efficiency of treatment.Shponka I.S.Gritsenko P.A.Kovtunenko A.V.The cancer of larynx is one of the most significant medical problems because of its high prevalence, high mortality and low survival rate. The retrospective analysis of specimens of 187 patients suffering from laryngeal squamous cell carcinoma of stage III-IV was performed. The purpose of our study was to substantiate the appropriateness of assessment of immunomorphological profile in estimation of biological behaviour of laryngeal cancer for prediction its clinical course and choice of optimal treatment. The routine histological examination with determination of type, histopathological grading and extention of tumors was performed. Molecular markers, such as CK19, CK34βЕ12, Ki-67, p53 and bcl-2 were analyzed by immunohistochemistry. Our findings were compared with the clinical course, presence of regional and distant metastasis, rate of relapses, one-year survival rate, and efficiency of treatment. The significant distinctions in marker expression among tumors with different clinical course and efficiency of treatment were determined which prove these markers prognostic significance. The cancers of the larynx with unfavorable clinical course had high proliferative activity, expression of р53, СК19 and low expression of СК34. The tumors that responded well to the treatment had high expression of р53 and low expression of bcl-2. The radiosensitive tumors also had high proliferative activity. The cancers which did not respond well to treatment had high expression of bcl-2 that allowed us to consider this marker to be independent factor of tumor resistance to treatment. These data give us the possibility to individualize treatment approaches to patients with laryngeal cancer.http://www.morphology.dp.ua/_pub/MORPHO-2007-01-02/07sisnpt.pdflaryngeal squamous cell carcinomaprognostic markerscytokeratinsproliferative activityp53bcl-2
spellingShingle Shponka I.S.
Gritsenko P.A.
Kovtunenko A.V.
Immunohistochemical profile of laryngeal cancers with different clinical course and efficiency of treatment.
Морфологія
laryngeal squamous cell carcinoma
prognostic markers
cytokeratins
proliferative activity
p53
bcl-2
title Immunohistochemical profile of laryngeal cancers with different clinical course and efficiency of treatment.
title_full Immunohistochemical profile of laryngeal cancers with different clinical course and efficiency of treatment.
title_fullStr Immunohistochemical profile of laryngeal cancers with different clinical course and efficiency of treatment.
title_full_unstemmed Immunohistochemical profile of laryngeal cancers with different clinical course and efficiency of treatment.
title_short Immunohistochemical profile of laryngeal cancers with different clinical course and efficiency of treatment.
title_sort immunohistochemical profile of laryngeal cancers with different clinical course and efficiency of treatment
topic laryngeal squamous cell carcinoma
prognostic markers
cytokeratins
proliferative activity
p53
bcl-2
url http://www.morphology.dp.ua/_pub/MORPHO-2007-01-02/07sisnpt.pdf
work_keys_str_mv AT shponkais immunohistochemicalprofileoflaryngealcancerswithdifferentclinicalcourseandefficiencyoftreatment
AT gritsenkopa immunohistochemicalprofileoflaryngealcancerswithdifferentclinicalcourseandefficiencyoftreatment
AT kovtunenkoav immunohistochemicalprofileoflaryngealcancerswithdifferentclinicalcourseandefficiencyoftreatment